2025年智慧药丸全球市场报告

近年来，智慧药丸市场快速扩张，市场规模从2024年的55.3亿美元成长至2025年的61.1亿美元，复合年增长率达10.3%。预测期内的成长可归因于服药依从性、慢性病管理、临床试验和研究以及人口老化等因素。

智慧药丸市场规模预计将在未来几年快速成长，到2029年将达到91.3亿美元，复合年增长率为10.6%。预测期内的成长可归因于远端患者监护、监管和品质标准、临床试验和研究以及数位健康整合。预测期内的主要趋势包括无线健康监测、诊断和成像胶囊、数据分析和人工智慧、智慧药丸感测器、小型化和生物相容性。

智慧药丸专为药物管理而设计，内建电子感测器，服用后会发出可被贴片或智慧型手机侦测到的讯号。这些创新药丸在确保患者遵医嘱服药和监测服药顺从性方面发挥关键作用。

智慧药丸的主要应用包括胶囊内视镜检查、病患监测和药物传递。病患监测涉及反覆或持续追踪患者的各种参数。智慧药丸针对消化道的特定区域，例如食道、胃、小肠和大肠，用于治疗食道、结肠和小肠疾病。这些检查可用于各种医疗保健机构，包括医院、诊断中心和研究机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供智慧药丸市场统计数据，例如智慧药丸行业的全球市场规模、各地区市场份额、竞争对手的市场份额、智慧药丸市场细分、市场趋势和商业机会，以及您在智慧药丸行业取得成功所需的数据。这份智慧药丸市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为10.6%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，具体表现为对主要从瑞典和新加坡进口的生物相容性感测器胶囊和pH敏感涂层的关税上调，从而推高可摄入诊断技术的成本。此外，这种影响还将透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易造成的负面影响，在更广泛的层面上显现。

智慧药丸市场的发展受到人们对非侵入性手术日益增长的偏好的推动。非侵入性手术是指不需要切口或组织切除的诊断和治疗方法。智慧药丸是无线、可吞嚥的胶囊，具有广泛的应用，包括胶囊内视镜检查、药物传输和病患监测。例如，它们在诊断成像，特别是胶囊内视镜检查中起着关键作用。在此过程中，吞下配备微型摄影机的智慧药丸，以捕捉食道、胃和小肠通过消化道时的影像。智慧药丸有可能彻底改变胃肠道疾病的诊断并取代内视镜检查等传统技术。因此，对非侵入性手术的偏好是智慧药丸市场的主要驱动力。

预计智慧药丸市场的成长将受到胃肠道疾病日益流行的进一步推动。胃肠道疾病会影响消化器官系统，包括胃、肠和相关器官。配备感测器和技术的智慧药丸正被用于监测和诊断胃肠道疾病，为了解消化器官系统的功能提供宝贵的见解。例如，截至 2022 年 9 月，美国国家医学图书馆报告称，腹泻、便秘和大肠激躁症(IBS) 等胃肠道疾病占全球人口的 40% 以上，盛行率分别为 4.7%、11.7% 和 4.1%。因此，胃肠道疾病发生率的上升是智慧药丸市场的主要驱动力。

目前，大量研究和开发正在进行中，旨在利用微型晶片（例如可寻址发射器 (ATOMS)）来製造智慧药丸，这些晶片以磁自旋的形式运作。 ATOMS 是硅晶片装置，它利用磁场精确定位患者体内原子的位置，并运用磁振造影(MRI) 的原理。它可以用于可吞服的智慧药丸，监测各种健康指标，包括胃肠道、血液、大脑、pH 值、体温、血压和血糖水平，并从体内诊断和治疗疾病。它甚至可以被编程来释放药物。例如，加州理工学院的科学家已经开发出一种可用作智慧药丸的微型医疗晶片。

为了获得竞争优势，智慧药丸市场的主要企业正专注于开发具有可定製程式的智慧药丸。可定製程序可实现个人化药物输送和健康监测，从而改善患者护理和治疗效果。例如，2022年9月，爱尔兰数位治疗公司HealthBeacon PLC推出了HB智慧药丸解决方案，使患者能够在家中管理多达九种口服药物。这项技术旨在提高患者服药顺从性，解决一半患者难以坚持服药计画的问题。 HB智慧药丸解决方案与患者援助计划无缝集成，为患者提供可自订的选项，可作为独立解决方案或现有产品的一部分。

智慧药丸市场的主要参与者包括美敦力公司、奥林巴斯公司、CapsoVision公司、诺华公司、Proteus Digital Health公司、荷兰皇家飞利浦公司、MicroCHIPS公司、Bio-Images Drug Delivery (BDD)有限公司、Given Imaging有限公司、Vitality公司、波士顿科学公司、HQ公司、富士胶片控股公司、通用电气公司、Check-Cap有限公司、IntroMedic有限公司、金山科技股份有限公司、宾得医疗、etectRx公司、Pixie Scientific HQ公司、ANX Robotica,alvery. Pill公司、Medisafe公司、AdhereTech有限责任公司和TabSafe Medical Services公司。

2024年，智慧药丸市场最大的地区是北美。在智慧药丸市场分析中，西欧是第二大地区。智慧药丸市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

智慧药丸市场报告涵盖以下国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

智慧药丸市场涵盖胶囊内视镜、药物传输和病患监测等应用中使用的设备的销售。该市场中的商品价值为出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球智慧药丸：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球智慧药丸市场：成长率分析
• 全球智慧药丸市场表现：规模与成长，2019-2024
• 全球智慧药丸市场预测：2024-2029年、2034年规模与成长
• 全球智慧药丸：总目标市场（TAM）

第六章 市场细分

• 全球智慧药丸市场：依目标机构、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 食道
• 胃
• 小肠
• 冒号
• 全球智慧药丸市场：按适应症、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 食道疾病
• 结肠疾病
• 小肠疾病
• 其他适应症
• 全球智慧药丸市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 胶囊内视镜
• 病患监测
• 药物输送
• 全球智慧药丸市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
• 医院
• 诊断中心
• 研究所
• 全球智慧药丸市场：按食道细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 食道疾病诊断片
• 食道运动监测片
• 全球智慧药丸市场：按胃类型细分、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 排放监测片
• 胃病诊断片
• 全球智慧药丸市场：按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 用于吸收研究的片剂
• 小肠疾病诊断片
• 全球智慧药丸市场：按结肠细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 大肠镜检查片剂
• 结肠疾病检测片

第七章 区域和国家分析

• 全球智慧药丸市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球智慧药丸市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 智慧药丸市场：竞争格局
• 智慧药丸市场：公司简介
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
  • CapsoVision Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Proteus Digital Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Koninklijke Philips NV
• MicroCHIPS Inc.
• Bio-Images Drug Delivery（BDD）Ltd.
• Given Imaging Ltd.
• Vitality Inc.
• Boston Scientific Corporation
• HQ Inc.
• Fujifilm Holdings Corporation
• General Electric Company
• Check-Cap Ltd.
• IntroMedic Co. Ltd.
• Jinshan Science & Technology Co. Ltd.
• PENTAX Medical
• etectRx Inc.
• Pixie Scientific HQ Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年智慧药丸市场：提供新机会的国家
• 2029年智慧药丸市场：细分市场带来新机会
• 2029年智慧药丸市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Smart pills are designed for the purpose of administering medication and are equipped with electronic sensors that emit signals detectable by patches or smartphones upon ingestion. These innovative pills play a crucial role in ensuring patients' adherence to their prescribed drug regimens and enable the monitoring of medication compliance.

The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The smart pills market research report is one of a series of new reports from The Business Research Company that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart pills market size has grown rapidly in recent years. It will grow from $5.53 billion in 2024 to $6.11 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to medication adherence, chronic disease management, clinical trials and research, aging population.

The smart pills market size is expected to see rapid growth in the next few years. It will grow to $9.13 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to remote patient monitoring, regulatory and quality standards, clinical trials and research, digital health integration. Major trends in the forecast period include wireless health monitoring, diagnostic and imaging capsules, data analytics and artificial intelligence, smart pill sensors, miniaturization and biocompatibility.

The forecast of 10.6% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on biocompatible sensor capsules and pH-sensitive coatings, mainly imported from Sweden and Singapore, raising costs for ingestible diagnostic technologies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The smart pills market is experiencing growth, driven by the increasing preference for non-invasive procedures. Non-invasive procedures refer to diagnostic and treatment methods that do not require incisions or tissue removal. Smart pills, which are wireless, ingestible capsules, are easily swallowed and have a wide range of applications in capsule endoscopy, drug delivery, and patient monitoring. For example, they play a crucial role in diagnostic imaging, particularly in capsule endoscopy, a procedure where a smart pill with a micro-camera is swallowed to capture images of the esophagus, stomach, and small intestine as it traverses the gastrointestinal (GI) tract. Smart pills have transformed the diagnosis of gastrointestinal disorders and have the potential to replace conventional techniques like endoscopy. Consequently, the preference for non-invasive procedures is a key driver of the smart pills market.

The growth of the smart pills market is expected to be further fueled by the increasing prevalence of gastrointestinal disorders. Gastrointestinal disorders affect the digestive system, including the stomach, intestines, and associated organs. Smart pills equipped with sensors and technology are utilized for monitoring and diagnosing gastrointestinal disorders, providing valuable insights into digestive system function. For example, as of September 2022, the National Library of Medicine reports that over 40% of people worldwide experience gastrointestinal problems such as diarrhea, constipation, and irritable bowel syndrome (IBS), with prevalence rates of 4.7%, 11.7%, and 4.1%, respectively. Therefore, the rising incidence of gastrointestinal disorders is a significant driver of the smart pills market.

Extensive research and development efforts are underway to harness miniature chips like Addressable Transmitters Operated as Magnetic Spins (ATOMS) for use in smart pills. ATOMS are silicon chip devices that use magnetic resonance imaging (MRI) principles to pinpoint the location of atoms within a patient's body using magnetic fields. They can be employed in ingestible smart pills for disease diagnosis and treatment from within the body, monitoring the gastrointestinal tract, blood, brain, and various health indicators like pH, temperature, pressure, and sugar concentrations. Additionally, they can be programmed to release medications. For instance, scientists at Caltech (California Institute of Technology) have developed a miniature medical chip for potential use as a smart pill.

Major companies in the smart pills market are concentrating on developing smart pills with customizable programs to gain a competitive advantage. Smart pills with customizable programs enable personalized drug delivery and health monitoring, enhancing patient care and treatment effectiveness. For example, in September 2022, HealthBeacon PLC, an Irish digital therapeutics company, introduced the HB Smart Pills Solution, aiding patients in managing up to nine oral medications at home. This technology aims to improve medication adherence, addressing the issue where one in two patients struggles to adhere to their medication schedules. The HB Smart Pills Solution seamlessly integrates with patient support programs, offering customizable options for patients as standalone solutions or as part of existing offerings.

Major companies operating in the smart pills market include Medtronic PLC, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.

North America was the largest region in the smart pills market in 2024. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Pills Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine
• 2) By Disease Indication: Esophageal Diseases, Colon Diseases, Small bowel Diseases, And Other Disease Indications
• 3) By Application: Capsule Endoscopy; Patient Monitoring; Drug Delivery
• 4) By End User: Hospital; Diagnostic Center; Research Institute
• Subsegments:
• 1) By Esophagus: Diagnostic Pills For Esophageal Disorders; Pills For Monitoring Esophageal Motility
• 2) By Stomach: Gastric Emptying Monitoring Pills; Diagnostic Pills For Gastric Disorders
• 3) By Small Intestine: Pills For Absorption Studies; Diagnostic Pills For Small Bowel Diseases
• 4) By Large Intestine: Colonoscopy Alternative Pills; Pills For Detecting Colorectal Disorders
• Companies Mentioned: Medtronic plc; Olympus Corporation; CapsoVision Inc.; Novartis AG; Proteus Digital Health Inc.; Koninklijke Philips N.V.; MicroCHIPS Inc.; Bio-Images Drug Delivery (BDD) Ltd.; Given Imaging Ltd.; Vitality Inc.; Boston Scientific Corporation; HQ Inc.; Fujifilm Holdings Corporation; General Electric Company; Check-Cap Ltd.; IntroMedic Co. Ltd.; Jinshan Science & Technology Co. Ltd.; PENTAX Medical; etectRx Inc.; Pixie Scientific HQ Inc.; ANX Robotica Corp.; RF Co. Ltd.; Shenzhen Jifu Medical Technology Co. Ltd.; Otsuka America Pharmaceutical Inc.; Medimetrics Personalized Drug Delivery B.V.; Smart Pill Inc.; Medisafe Inc.; AdhereTech LLC; TabSafe Medical Services Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Pills Market Characteristics

3. Smart Pills Market Trends And Strategies

4. Smart Pills Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Smart Pills Growth Analysis And Strategic Analysis Framework

• 5.1. Global Smart Pills PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Smart Pills Market Growth Rate Analysis
• 5.4. Global Smart Pills Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Smart Pills Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Smart Pills Total Addressable Market (TAM)

6. Smart Pills Market Segmentation

• 6.1. Global Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Esophagus
• Stomach
• Small Intestine
• Large Intestine
• 6.2. Global Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Esophageal Diseases
• Colon Diseases
• Small bowel Diseases
• Other Disease Indications
• 6.3. Global Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsule Endoscopy
• Patient Monitoring
• Drug Delivery
• 6.4. Global Smart Pills Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostic Center
• Research Institute
• 6.5. Global Smart Pills Market, Sub-Segmentation Of Esophagus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Pills For Esophageal Disorders
• Pills For Monitoring Esophageal Motility
• 6.6. Global Smart Pills Market, Sub-Segmentation Of Stomach, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastric Emptying Monitoring Pills
• Diagnostic Pills For Gastric Disorders
• 6.7. Global Smart Pills Market, Sub-Segmentation Of Small Intestine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pills For Absorption Studies
• Diagnostic Pills For Small Bowel Diseases
• 6.8. Global Smart Pills Market, Sub-Segmentation Of Large Intestine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Colonoscopy Alternative Pills
• Pills For Detecting Colorectal Disorders

7. Smart Pills Market Regional And Country Analysis

• 7.1. Global Smart Pills Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Smart Pills Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Pills Market

• 8.1. Asia-Pacific Smart Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Pills Market

• 9.1. China Smart Pills Market Overview
• 9.2. China Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Pills Market

• 10.1. India Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Pills Market

• 11.1. Japan Smart Pills Market Overview
• 11.2. Japan Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Pills Market

• 12.1. Australia Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Pills Market

• 13.1. Indonesia Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Pills Market

• 14.1. South Korea Smart Pills Market Overview
• 14.2. South Korea Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Pills Market

• 15.1. Western Europe Smart Pills Market Overview
• 15.2. Western Europe Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Pills Market

• 16.1. UK Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Pills Market

• 17.1. Germany Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Pills Market

• 18.1. France Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Pills Market

• 19.1. Italy Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Pills Market

• 20.1. Spain Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Pills Market

• 21.1. Eastern Europe Smart Pills Market Overview
• 21.2. Eastern Europe Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Pills Market

• 22.1. Russia Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Pills Market

• 23.1. North America Smart Pills Market Overview
• 23.2. North America Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Pills Market

• 24.1. USA Smart Pills Market Overview
• 24.2. USA Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Pills Market

• 25.1. Canada Smart Pills Market Overview
• 25.2. Canada Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Pills Market

• 26.1. South America Smart Pills Market Overview
• 26.2. South America Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Pills Market

• 27.1. Brazil Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Pills Market

• 28.1. Middle East Smart Pills Market Overview
• 28.2. Middle East Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Pills Market

• 29.1. Africa Smart Pills Market Overview
• 29.2. Africa Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Smart Pills Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Pills Market Competitive Landscape And Company Profiles

• 30.1. Smart Pills Market Competitive Landscape
• 30.2. Smart Pills Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. CapsoVision Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Proteus Digital Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Smart Pills Market Other Major And Innovative Companies

• 31.1. Koninklijke Philips N.V.
• 31.2. MicroCHIPS Inc.
• 31.3. Bio-Images Drug Delivery (BDD) Ltd.
• 31.4. Given Imaging Ltd.
• 31.5. Vitality Inc.
• 31.6. Boston Scientific Corporation
• 31.7. HQ Inc.
• 31.8. Fujifilm Holdings Corporation
• 31.9. General Electric Company
• 31.10. Check-Cap Ltd.
• 31.11. IntroMedic Co. Ltd.
• 31.12. Jinshan Science & Technology Co. Ltd.
• 31.13. PENTAX Medical
• 31.14. etectRx Inc.
• 31.15. Pixie Scientific HQ Inc.

32. Global Smart Pills Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Pills Market

34. Recent Developments In The Smart Pills Market

35. Smart Pills Market High Potential Countries, Segments and Strategies

• 35.1 Smart Pills Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Smart Pills Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Smart Pills Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer